Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 548

1.

Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia.

Yolland CO, Hanratty D, Neill E, Rossell SL, Berk M, Dean OM, Castle DJ, Tan EJ, Phillipou A, Harris AW, Barreiros AR, Hansen A, Siskind D.

Aust N Z J Psychiatry. 2019 Dec 11:4867419893439. doi: 10.1177/0004867419893439. [Epub ahead of print]

PMID:
31826654
2.

The present and future of the severe mental illness (SMI) policies: reflections from an Asia Pacific Expert Forum series.

Wong MM, Castle D, Organ B, Li J, Ma L, Chui E, Ho K, Hung SF, Lo TL, Szeto WL, Yeung WS, Ahmed AI, Desai N, Thirthalli J, Yamanouchi Y, Hwang TY, Lee MS, Lai TJ, Yang YK, Karamustafalioglu O.

Psychiatry Clin Neurosci. 2019 Dec 6. doi: 10.1111/pcn.12964. [Epub ahead of print] No abstract available.

PMID:
31808969
3.

Exploring the relationships between illness perceptions, self-efficacy, coping strategies, psychological distress and quality of life in a cohort of adults with diabetes mellitus.

Knowles SR, Apputhurai P, O'Brien CL, Ski CF, Thompson DR, Castle DJ.

Psychol Health Med. 2019 Dec 2:1-15. doi: 10.1080/13548506.2019.1695865. [Epub ahead of print]

PMID:
31790287
4.

Delusional themes in Body Dysmorphic Disorder (BDD): Comparisons with psychotic disorders and non-clinical Controls.

Rossell SL, Labuschagne I, Castle DJ, Toh WL.

Psychiatry Res. 2019 Nov 18:112694. doi: 10.1016/j.psychres.2019.112694. [Epub ahead of print]

PMID:
31785950
5.

Psilocybin-assisted therapy for depression: How do we advance the field?

Meikle SE, Liknaitzky P, Rossell SL, Ross M, Strauss N, Thomas N, Murray G, Williams M, Castle DJ.

Aust N Z J Psychiatry. 2019 Nov 22:4867419888575. doi: 10.1177/0004867419888575. [Epub ahead of print]

PMID:
31752499
6.

Editorial: Smoking and Schizophrenia.

Castle D, Baker AL, Bonevski B.

Front Psychiatry. 2019 Oct 17;10:738. doi: 10.3389/fpsyt.2019.00738. eCollection 2019. No abstract available.

7.

Serum lipids and suicidality among patients with schizophrenia.

Sankaranarayanan A, Jenkins Z, Castle D, Andrade C.

Schizophr Res. 2019 Oct 11. pii: S0920-9964(19)30435-9. doi: 10.1016/j.schres.2019.10.004. [Epub ahead of print] No abstract available.

PMID:
31611043
8.

New Zealand's big psychotherapy programme requires evaluation.

Bastiampillai T, Allison S, Castle D, Beaglehole B, Mulder R.

N Z Med J. 2019 Sep 20;132(1502):8-10. No abstract available.

PMID:
31563922
9.

Protocol for an Economic Evaluation of the Quitlink Randomized Controlled Trial for Accessible Smoking Cessation Support for People With Severe Mental Illness.

Sweeney R, Moodie M, Baker AL, Borland R, Castle D, Segan C, Turner A, Attia J, Kelly PJ, Brophy L, Bonevski B, Williams JM, Baird D, White SL, McCarter K.

Front Psychiatry. 2019 Sep 3;10:618. doi: 10.3389/fpsyt.2019.00618. eCollection 2019.

10.

Psychiatric bed numbers in Australia.

Allison S, Bastiampillai T, Copolov D, Castle D.

Lancet Psychiatry. 2019 Oct;6(10):e21. doi: 10.1016/S2215-0366(19)30208-1. No abstract available.

PMID:
31544765
11.

Medical Marijuana: The Australian Experience.

Castle DJ, Strauss N, Norman A, Bonomo Y.

Mo Med. 2019 Jul-Aug;116(4):270-273. No abstract available.

12.

The effect of mindfulness training prior to total joint arthroplasty on post-operative pain and physical function: A randomised controlled trial.

Dowsey M, Castle D, Knowles S, Monshat K, Salzberg M, Nelson E, Dunin A, Dunin J, Spelman T, Choong P.

Complement Ther Med. 2019 Oct;46:195-201. doi: 10.1016/j.ctim.2019.08.010. Epub 2019 Aug 12.

PMID:
31519279
13.

Does early intervention prevent chronic psychosis? A question for the Victorian Royal Commission into Mental Health.

Allison S, Bastiampillai T, Malhi GS, Castle D.

Aust N Z J Psychiatry. 2019 Oct;53(10):943-945. doi: 10.1177/0004867419873717. Epub 2019 Sep 5. No abstract available.

PMID:
31486340
14.

Psychosocial Factors Affecting Smoking Cessation Among People Living With Schizophrenia: A Lived Experience Lens.

Cocks N, Brophy L, Segan C, Stratford A, Jones S, Castle D.

Front Psychiatry. 2019 Aug 15;10:565. doi: 10.3389/fpsyt.2019.00565. eCollection 2019.

15.

High-definition transcranial direct current stimulation in anorexia nervosa: A pilot study.

Phillipou A, Kirkovski M, Castle DJ, Gurvich C, Abel LA, Miles S, Rossell SL.

Int J Eat Disord. 2019 Nov;52(11):1274-1280. doi: 10.1002/eat.23146. Epub 2019 Aug 21.

PMID:
31433523
16.

Treatment of progressive multifocal leukoencephalopathy.

Castle D, Robertson NP.

J Neurol. 2019 Oct;266(10):2587-2589. doi: 10.1007/s00415-019-09501-y. No abstract available.

17.

Integrating Patients' Expectations into the Management of Their Depression: Report of a Symposium at the European College of Neuropsychopharmacology Congress.

Demyttenaere K, Frank E, Castle D, Cindik-Herbrüggen E.

Adv Ther. 2019 Oct;36(Suppl 3):73-90. doi: 10.1007/s12325-019-01038-w. Epub 2019 Aug 9.

18.

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.

Castle D, Robertson NP.

J Neurol. 2019 Sep;266(9):2338-2340. doi: 10.1007/s00415-019-09485-9. No abstract available.

19.

Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international survey.

Kurokawa S, Kishimoto T, Su KP, Chang JP, Chang HC, Yu X, Rodrigues-Silva N, Nielsen J, Unadkat A, Castle D, Haddad PM, Rocha D, Gadelha A, Kaliora S, Petrides G, Agid O, Tazawa Y, Takamiya A, Horigome T, Kane JM.

Schizophr Res. 2019 Sep;211:105-107. doi: 10.1016/j.schres.2019.07.028. Epub 2019 Jul 29. No abstract available.

PMID:
31371039
20.

The challenges facing the public mental health sector: implications of the Victorian Psychiatry workforce project.

Newton R, Beasley A, Bosanac P, Castle D, Copolov D, Hopwood M, Keks N, Paoletti N, Tiller J.

Australas Psychiatry. 2019 Jul 25:1039856219852284. doi: 10.1177/1039856219852284. [Epub ahead of print]

PMID:
31342777
21.

The relationship between physical activity levels and symptoms of depression, anxiety and stress in individuals with alopecia Areata.

Rajoo Y, Wong J, Cooper G, Raj IS, Castle DJ, Chong AH, Green J, Kennedy GA.

BMC Psychol. 2019 Jul 23;7(1):48. doi: 10.1186/s40359-019-0324-x.

22.

Is there a discrete negative symptom syndrome in people who use methamphetamine?

Voce A, Burns R, Castle D, Calabria B, McKetin R.

Compr Psychiatry. 2019 Aug;93:27-32. doi: 10.1016/j.comppsych.2019.06.002. Epub 2019 Jun 28.

23.

Self- screening using the Edinburgh post natal depression scale for mothers and fathers to initiate early help seeking behaviours.

Edward KL, Giandinoto JA, Stephenson J, Mills C, Mcfarland J, Castle DJ.

Arch Psychiatr Nurs. 2019 Aug;33(4):421-427. doi: 10.1016/j.apnu.2019.05.007. Epub 2019 May 25.

PMID:
31280789
24.

Psychosocial interventions for stroke survivors, carers and survivor-carer dyads: a systematic review and meta-analysis.

Minshall C, Pascoe MC, Thompson DR, Castle DJ, McCabe M, Chau JPC, Jenkins Z, Cameron J, Ski CF.

Top Stroke Rehabil. 2019 Oct;26(7):554-564. doi: 10.1080/10749357.2019.1625173. Epub 2019 Jun 30.

PMID:
31258017
25.

Using biomarkers to predict clinical outcomes in multiple sclerosis.

Castle D, Wynford-Thomas R, Loveless S, Bentley E, Howell OW, Tallantyre EC.

Pract Neurol. 2019 Aug;19(4):342-349. doi: 10.1136/practneurol-2018-002000. Epub 2019 Jun 26.

PMID:
31243138
26.

Antipsychotic choice: understanding shared decision-making among doctors and patients.

Yeo V, Dowsey M, Alguera-Lara V, Ride J, Lancsar E, Castle DJ.

J Ment Health. 2019 Jun 26:1-8. doi: 10.1080/09638237.2019.1630719. [Epub ahead of print]

PMID:
31240989
27.

Dysmorphic concern in anorexia nervosa: Implications for recovery.

Beilharz F, Phillipou A, Castle D, Jenkins Z, Cistullo L, Rossell S.

Psychiatry Res. 2019 Mar;273:657-661. doi: 10.1016/j.psychres.2019.01.102. Epub 2019 Jan 31.

PMID:
31207849
28.

A systematic review of efficacy of Collaborative Assessment and Management of Suicidality (CAMS) in managing suicide risk and deliberate self-harm in adult populations.

Hanratty D, Kilicaslan J, Wilding H, Castle D.

Australas Psychiatry. 2019 Jun 11:1039856219848832. doi: 10.1177/1039856219848832. [Epub ahead of print]

PMID:
31184492
29.

Peer mentoring for eating disorders: results from the evaluation of a pilot program.

Beveridge J, Phillipou A, Jenkins Z, Newton R, Brennan L, Hanly F, Torrens-Witherow B, Warren N, Edwards K, Castle D.

J Eat Disord. 2019 Jun 3;7:13. doi: 10.1186/s40337-019-0245-3. eCollection 2019.

30.

Intranasal oxytocin alters amygdala-temporal resting-state functional connectivity in body dysmorphic disorder: A double-blind placebo-controlled randomized trial.

Grace SA, Labuschagne I, Castle DJ, Rossell SL.

Psychoneuroendocrinology. 2019 Sep;107:179-186. doi: 10.1016/j.psyneuen.2019.05.022. Epub 2019 May 22.

PMID:
31146138
31.

Impaired Recognition of Negative Facial Emotions in Body Dysmorphic Disorder.

Grace SA, Toh WL, Buchanan B, Castle DJ, Rossell SL.

J Int Neuropsychol Soc. 2019 Sep;25(8):884-889. doi: 10.1017/S1355617719000419. Epub 2019 May 17.

PMID:
31099324
32.

The He Ara Oranga Report: What's wrong with 'Big Psychiatry' in New Zealand?

Allison S, Bastiampillai T, Castle D, Mulder R, Beaglehole B.

Aust N Z J Psychiatry. 2019 Aug;53(8):724-726. doi: 10.1177/0004867419848840. Epub 2019 May 16. No abstract available.

PMID:
31094207
33.

The Australian drug harms ranking study.

Bonomo Y, Norman A, Biondo S, Bruno R, Daglish M, Dawe S, Egerton-Warburton D, Karro J, Kim C, Lenton S, Lubman DI, Pastor A, Rundle J, Ryan J, Gordon P, Sharry P, Nutt D, Castle D.

J Psychopharmacol. 2019 Jul;33(7):759-768. doi: 10.1177/0269881119841569. Epub 2019 May 13. Erratum in: J Psychopharmacol. 2019 Nov;33(11):1471.

PMID:
31081439
34.

The complexities of the borderline patient: how much more complex when considering physical health?

Castle DJ.

Australas Psychiatry. 2019 May 9:1039856219848833. doi: 10.1177/1039856219848833. [Epub ahead of print]

PMID:
31070464
35.

Faecal microbiota transplants for depression - Who gives a crapsule?

Green J, Castle D, Berk M, Hair C, Loughman A, Cryan J, Nierenberg A, Athan E, Jacka F.

Aust N Z J Psychiatry. 2019 Aug;53(8):732-734. doi: 10.1177/0004867419839776. Epub 2019 Apr 8. No abstract available.

PMID:
30957511
36.

"Quitlink"-A Randomized Controlled Trial of Peer Worker Facilitated Quitline Support for Smokers Receiving Mental Health Services: Study Protocol.

Baker AL, Borland R, Bonevski B, Segan C, Turner A, Brophy L, McCarter K, Kelly PJ, Williams JM, Baird D, Attia J, Sweeney R, White SL, Filia S, Castle D.

Front Psychiatry. 2019 Mar 19;10:124. doi: 10.3389/fpsyt.2019.00124. eCollection 2019.

37.

Beyond psychiatry: motivations for considering an Australian wellbeing program within Malaysian health services.

Silim UA, Suhaimi AF, Moore G, Ryan B, Castle DJ.

Australas Psychiatry. 2019 Jun;27(3):262-266. doi: 10.1177/1039856219834074. Epub 2019 Apr 1.

PMID:
30931582
38.

Body parts of clinical concern in anorexia nervosa versus body dysmorphic disorder: a cross-diagnostic comparison.

Toh WL, Grace SA, Rossell SL, Castle DJ, Phillipou A.

Australas Psychiatry. 2019 Apr 1:1039856219839477. doi: 10.1177/1039856219839477. [Epub ahead of print]

PMID:
30931578
39.

Should skin picking disorder be considered a diagnostic category? A systematic review of the evidence.

Jenkins Z, Zavier H, Phillipou A, Castle D.

Aust N Z J Psychiatry. 2019 Sep;53(9):866-877. doi: 10.1177/0004867419834347. Epub 2019 Mar 21.

PMID:
30895799
40.

Is it really safe to cut psychiatric beds in Western Sydney by 15%? A reply to Atkinson et al.

Allison S, Bastiampillai T, Castle D, Judkins S.

Aust N Z J Psychiatry. 2019 Oct;53(10):1026. doi: 10.1177/0004867419835949. Epub 2019 Mar 18. No abstract available.

PMID:
30880402
41.

Direct comparisons of anorexia nervosa and body dysmorphic disorder: A systematic review.

Phillipou A, Castle DJ, Rossell SL.

Psychiatry Res. 2019 Apr;274:129-137. doi: 10.1016/j.psychres.2019.01.106. Epub 2019 Feb 1.

PMID:
30784781
42.

Hospital psychiatry: is it adequately funded to meet rising patient demand?

Allison S, Bastiampillai T, Castle D.

Australas Psychiatry. 2019 Feb;27(1):5-6. doi: 10.1177/1039856218818316. No abstract available.

PMID:
30755002
43.

A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated PsychosisSubstance Use and Misuse.

Voce A, Calabria B, Burns R, Castle D, McKetin R.

Subst Use Misuse. 2019;54(4):549-559. doi: 10.1080/10826084.2018.1521430. Epub 2019 Jan 29.

PMID:
30693832
44.

An Overlooked Brain Region in the Aetiology of Anorexia Nervosa: The Importance of Behaviourally Driven Neuroimaging Analysis.

Phillipou A, Castle DJ, Abel LA, Gurvich C, Rossell SL.

J Exp Neurosci. 2018 Dec 20;12:1179069518820068. doi: 10.1177/1179069518820068. eCollection 2018.

45.

Reducing Smoking Among People With Schizophrenia: Perspectives on Priorities for Advancing Research.

Baker AL, Robson D, Lawn S, Steinberg ML, Bucci S, McNeill A, Castle DJ, Bonevski B.

Front Psychiatry. 2018 Dec 18;9:711. doi: 10.3389/fpsyt.2018.00711. eCollection 2018.

46.

Visual training program for body dysmorphic disorder: protocol for a novel intervention pilot and feasibility trial.

Beilharz F, Castle DJ, Phillipou A, Rossell SL.

Pilot Feasibility Stud. 2018 Dec 21;4:189. doi: 10.1186/s40814-018-0384-3. eCollection 2018.

47.

The SMILES trial: an important first step.

Jacka FN, O'Neil A, Itsiopoulos C, Opie R, Cotton S, Mohebbi M, Castle D, Dash S, Mihalopoulos C, Chatterton ML, Brazionis L, Dean OM, Hodge A, Berk M.

BMC Med. 2018 Dec 28;16(1):237. doi: 10.1186/s12916-018-1228-y.

48.

Correction to: A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial).

Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, Castle D, Dash S, Mihalopoulos C, Chatterton ML, Brazionis L, Dean OM, Hodge AM, Berk M.

BMC Med. 2018 Dec 28;16(1):236. doi: 10.1186/s12916-018-1220-6.

49.

Body dysmorphia in dentistry and prosthodontics: A practice based study.

Pérez Rodríguez C, Judge RB, Castle D, Phillipou A.

J Dent. 2019 Feb;81:33-38. doi: 10.1016/j.jdent.2018.12.003. Epub 2018 Dec 21.

PMID:
30579858
50.

Latent Psychotic Symptom Profiles Amongst People Who Use Methamphetamine: What Do They Tell Us About Existing Diagnostic Categories?

McKetin R, Voce A, Burns R, Ali R, Lubman DI, Baker AL, Castle DJ.

Front Psychiatry. 2018 Nov 19;9:578. doi: 10.3389/fpsyt.2018.00578. eCollection 2018.

Supplemental Content

Loading ...
Support Center